JP2021529168A5 - - Google Patents

Info

Publication number
JP2021529168A5
JP2021529168A5 JP2020570716A JP2020570716A JP2021529168A5 JP 2021529168 A5 JP2021529168 A5 JP 2021529168A5 JP 2020570716 A JP2020570716 A JP 2020570716A JP 2020570716 A JP2020570716 A JP 2020570716A JP 2021529168 A5 JP2021529168 A5 JP 2021529168A5
Authority
JP
Japan
Prior art keywords
groups
optionally substituted
disease
alkyl
methyl
Prior art date
Application number
JP2020570716A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020002950A5 (https=
JP7510358B2 (ja
JP2021529168A (ja
Filing date
Publication date
Priority claimed from GBGB1810668.2A external-priority patent/GB201810668D0/en
Application filed filed Critical
Publication of JP2021529168A publication Critical patent/JP2021529168A/ja
Publication of JP2021529168A5 publication Critical patent/JP2021529168A5/ja
Publication of JPWO2020002950A5 publication Critical patent/JPWO2020002950A5/ja
Application granted granted Critical
Publication of JP7510358B2 publication Critical patent/JP7510358B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020570716A 2018-06-28 2019-06-28 Ｔｒｋ受容体の調節剤としての４－置換フェニル－１，３，５－トリアジン誘導体 Active JP7510358B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1810668.2A GB201810668D0 (en) 2018-06-28 2018-06-28 New compounds
GB1810668.2 2018-06-28
PCT/GB2019/051853 WO2020002950A1 (en) 2018-06-28 2019-06-28 4-substituted phenyl-1,3,5-triazine derivatives as modulators of trk receptors

Publications (4)

Publication Number Publication Date
JP2021529168A JP2021529168A (ja) 2021-10-28
JP2021529168A5 true JP2021529168A5 (https=) 2022-06-30
JPWO2020002950A5 JPWO2020002950A5 (https=) 2022-06-30
JP7510358B2 JP7510358B2 (ja) 2024-07-03

Family

ID=63143731

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020570716A Active JP7510358B2 (ja) 2018-06-28 2019-06-28 Ｔｒｋ受容体の調節剤としての４－置換フェニル－１，３，５－トリアジン誘導体

Country Status (10)

Country Link
US (1) US11840524B2 (https=)
EP (1) EP3814335B1 (https=)
JP (1) JP7510358B2 (https=)
KR (1) KR20210024531A (https=)
CN (1) CN112513032B (https=)
BR (1) BR112020026619A2 (https=)
CA (1) CA3104237A1 (https=)
ES (1) ES2935183T3 (https=)
GB (1) GB201810668D0 (https=)
WO (1) WO2020002950A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA52415A (fr) 2018-02-26 2021-01-06 AlzeCure Pharma AB Dérivés de triazine pour le traitement de maladies associées à des neurotrophines
GB201912404D0 (en) * 2019-08-29 2019-10-16 AlzeCure Pharma AB New compounds
AU2021283892A1 (en) * 2020-06-03 2023-02-02 Dana-Farber Cancer Institute, Inc. Inhibitors of transcriptional enhanced associate domain (TEAD) and uses thereof
WO2025232990A1 (en) 2024-05-09 2025-11-13 AlzeCure Pharma AB Triazinone derivatives for use in the treatment of inflammation

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246109A1 (de) 1972-09-20 1974-03-28 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazinderivate, ein verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2313721A1 (de) 1973-03-20 1974-10-03 Bayer Ag Neue 1-phenylsubstituierte 1,3,5triazine, verfahren zu ihrer herstellung, sowie ihre verwendung als arzneimittel
DE2413722C3 (de) * 1974-03-21 1982-04-08 Bayer Ag, 5090 Leverkusen Neue 1-(4-Phenoxy-phenyl)-1,3,5-triazin-Derivate, ein Verfahren zu ihrer Herstellung sowie ihre Anwendung als Arzneimittel
DE2718799A1 (de) 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
CA1185974A (en) 1981-12-03 1985-04-23 Adolf Parg 1,3,5-triazinones and their use for controlling undesirable plant growth
DE3314739A1 (de) 1983-04-23 1984-10-25 Bayer Ag, 5090 Leverkusen 1-(4-(4-(fluoralkylmethylthio- oder -sulfinyl- oder -sulfonyl-)phenoxy) phenyl)-1,3,5-triazin-2,4,6(1h,3h,5h)-trione, verfahren zu ihrer herstellung und ihre verwendung als coccidiosemittel
DE3408768A1 (de) 1984-03-09 1985-09-12 Bayer Ag, 5090 Leverkusen Immunstimulierende mittel
DE3516632A1 (de) 1985-05-09 1986-11-13 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 1,3,5-triazintrionen
DE3516631A1 (de) 1985-05-09 1986-11-13 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 3-methyl-1,3,5-triazintrionen
DE3703105A1 (de) 1987-02-03 1988-08-11 Bayer Ag Mittel gegen protozoen bei insekten
DE3810080A1 (de) 1988-03-25 1989-10-05 Bayer Ag Trisubstituierte 1,3,5-triazin-2,4,6-trione
DE3814323A1 (de) 1988-04-28 1989-11-09 Hoechst Ag Wasserloesliche zubereitungen von coccidiostatica
US4933341A (en) 1988-10-08 1990-06-12 Bayer Aktiengesellschaft Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
DE4000624A1 (de) 1990-01-11 1991-07-18 Bayer Ag Fungizide verwendung von trisubstituierten 1,3,5-triazin-2,4,6-trionen, neue trisubstituierte 1,3,5-triazin-2,4,6-trione und verfahren zu ihrer herstellung
DE4329096A1 (de) 1993-08-30 1995-03-02 Bayer Ag Heterocyclylbenzoheterocyclen
CZ146296A3 (en) 1995-06-02 1997-04-16 American Cyanamid Co 3-(3-aryloxyphenyl)-1-(substituted methyl)-s-triazine-2,4,6-oxo or thiotriones, process of their preparation and herbicidal agents
US5519133A (en) 1995-06-02 1996-05-21 American Cyanamid Co. 3-(3-aryloxyphenyl)-1-(substituted methyl)-s-triazine-2,4,6-oxo or thiotrione herbicidal agents
US5726126A (en) * 1995-06-02 1998-03-10 American Cyanamid Company 1-(3-heterocyclyphenyl)-S-triazine-2,6,6-oxo or thiotrione herbicidal agents
US5604180A (en) 1995-06-02 1997-02-18 Crews, Jr.; Alvin D. 3-(3-aryloxyphenyl)-1 (substituted methyl)-s-triazine-2,4,6-oxo or thiotrione herbicidal agents
US5679791A (en) 1996-07-25 1997-10-21 American Cyanamid Company 1-(3-heterocyclylphenyl)-s-triazine-2,4,6-oxo or thiotrione herbicidal agents
MXPA01003542A (es) 1998-10-08 2002-09-18 New Ace Res Company Composiciones y metodos nuevos para la prevencion y tratamiento de enfermedad causada por protozoarios.
AU2198100A (en) 1998-12-22 2000-07-12 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
DE19937500A1 (de) 1999-08-09 2001-02-15 Bayer Ag Substituierte Heterocyclylbenzofurane
DE19958388A1 (de) 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
US6444615B1 (en) 2000-04-18 2002-09-03 Dow Agrosciences Llc Herbicidal imidazolidinetrione and thioxo-imidazolidinediones
DE10034800A1 (de) 2000-07-18 2002-01-31 Bayer Ag Substituierte Benzostickstoffheterocyclen
DE10040174A1 (de) 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE10040110A1 (de) 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen
AU2002324586B2 (en) 2001-08-02 2008-04-24 Neurocrine Biosciences, Inc. 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
US6861523B2 (en) 2002-02-08 2005-03-01 Torrey Pines Institute For Molecular Studies 1,3,5- trisubstituted-1,3,5-triazine-2,4,6-trione compounds and libraries
WO2003101980A1 (en) 2002-05-30 2003-12-11 Solvay Pharmaceuticals B.V. 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
US7241763B2 (en) 2002-07-15 2007-07-10 Janssen Pharmaceutica N.V. 3-furanyl analogs of toxoflavine as kinase inhibitors
DE102006038292A1 (de) 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
WO2008148008A1 (en) * 2007-05-23 2008-12-04 Emory University High throughput bioassay for identifying selective trka receptor agonists, and gambogic amide, a selective trka agonist with neuroprotective activity
US20120004310A1 (en) 2010-05-28 2012-01-05 Longo Frank M Non-peptide bdnf neurotrophin mimetics
RU2015141934A (ru) 2013-03-15 2017-04-20 Фарматрофикс, Инк. Непептидные миметики нейротрофина bdnf
MX2016008842A (es) 2014-01-20 2016-11-08 Hoffmann La Roche Derivados de n-fenil-lactama capaces de estimular la neurogenesis y su uso en el tratamiento de trastornos neurologicos.
MX387871B (es) 2014-12-10 2025-03-19 Mars Inc Metodos para modular los receptores del gusto.
JP2020502225A (ja) 2016-12-21 2020-01-23 アルゼキュア ファーマ アーべー トリアジントリオン誘導体、ならびにニューロトロフィン受容体および受容体型チロシンキナーゼのモジュレーターとしてのその使用。
MA52415A (fr) 2018-02-26 2021-01-06 AlzeCure Pharma AB Dérivés de triazine pour le traitement de maladies associées à des neurotrophines
GB201810669D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds
GB201912404D0 (en) 2019-08-29 2019-10-16 AlzeCure Pharma AB New compounds

Similar Documents

Publication Publication Date Title
JP2021529168A5 (https=)
JP6847093B2 (ja) ムスカリン様アゴニスト
US7999006B2 (en) Methods of using MEK inhibitors
AU2026200636A1 (en) Substituted cycloalkyls as modulators of the integrated stress pathway
JP2020530446A5 (https=)
JP2021006571A (ja) ムスカリンｍ１受容体アゴニストとしての二環式アザ化合物
JP2019515931A5 (https=)
JP2025013344A (ja) Ｉｌ－１７ａモジュレーターおよびその使用
EP1809601B1 (en) Compounds for alzheimer's disease
CA3180819A1 (en) Substituted aminothiazoles as dgkzeta inhibitors for immune activation
JP2021517893A5 (https=)
JP2010518026A5 (https=)
JP5667684B2 (ja) 関節炎の治療方法
US9034871B2 (en) Compounds for Alzheimer's disease
JP2021514963A5 (https=)
JP7362600B2 (ja) Ｒｉｐ１キナーゼ阻害剤として使用するための二環式化合物
IL276624B1 (en) Triazine derivatives for the treatment of neurotrophin-related diseases
AU2021268223B2 (en) Compound having KDM5 inhibitory activity and pharmaceutical use thereof
TW201920153A (zh) 具有環狀構造的化合物
HUP0200441A2 (hu) Tetrahidropiránszármazékok és terápiás szerként való alkalmazásuk és eljárás a vegyületek előállítására
JP2023548169A (ja) 統合的ストレス経路の調節剤
JP2021535137A5 (https=)
US8420810B2 (en) Bicyclic heterocyclic compound
RU2020115915A (ru) Бициклические сульфоны и сульфоксиды и способы их применения
US11840524B2 (en) 4-substituted phenyl-1,3,5-triazine derivatives as modulators of TrK receptors